The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...

A Boston Scientific executive said that the company received FDA approval for its Farapoint pulsed field ablation (PFA) ...

Field Medical Inc., a clinical-stage medical technology company advancing a versatile, next-generation pulsed field ablation ...

Boston Scientific Corp.'s Farapoint, its latest pulsed field ablation catheter, received U.S. FDA approval for use as an adjunctive device when treating persistent atrial fibrillation that requires ...

Field Medical Inc., a clinical-stage medical technology company advancing a versatile, next-generation pulsed field ablation ...

Boston Scientific expects incredibly high growth for its pulsed field ablation (PFA) devices, driven by increased usage of its existing catheters.

Boston Scientific’s $374/share Penumbra deal boosts mechanical thrombectomy exposure and growth. Click here to learn more ...

One of the most durable, and often underappreciated, drivers of earnings quality among MedTech companies is a favorable ...

Boston Scientific has enjoyed success in the cardiac device space, but it continues to look to gain market share elsewhere, ...

DoorDash, LVMH, and Home Depot are just some of the stocks our panelists favor this year. How AI is changing the game for ...